Current guidelines for cervical cancer screening

Journal of the American Academy of Nurse Practitioners

Volumn 24, Issue 7, 2012, Pages 417-424

  Schwaiger, Constance ^a   Aruda, Mary ^b   Lacoursiere, Sheryl ^b   Rubin, Richard ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

HPV screening; Management of cervical HPV; Pap smear guidelines; Reproductive health; Screening guidelines

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; METHODOLOGY; NURSING; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; UNITED STATES; UTERINE CERVIX TUMOR; VAGINA SMEAR; WOMEN'S HEALTH;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84862836278     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2012.00704.x     Document Type: Article

References (24)

1. ACOG Practice Bulletin 109. (2009). Cervical cytology screening. Obstetrics and Gynecology, 114, 1409-1420.
2. Albert, R. H., & Clark, M. M. (2008). Cancer screening in the older patient. American Family Physician, 78, 1369-1374.
3. American Cancer Society (ACS). (2002). Guidelines. Retrieved from
4. Arbyn, M., Ronco, G., Cuzick, J., Wentzensen, N., & Castle, P. (2009). How to evaluate emerging technologies in cervical cancer screening International Journal of Cancer, 125, 2489-2496. doi:
5. Datta, S. D., Koutshky, L. A., Ratelle, S., Unger, E. R., Shlay, J., McClain, R., Weinstock, H. (2008). Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Annals of Internal Medicine, 148, 493-457.
6. Fletcher, A. H., Wilkinson, E. J., & Knapik, J. A. (2009). Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance. Journal of Lower Genital Tract Disease, 13, 28-32. doi:
7. Kinney, W., Fetterman, B., Cox, J. T., Lorey, T., Flanagan, T., & Castle, P. E. (2011). Characteristics of 44 cervical cancers diagnosed following pap-negative, high risk HPV-positive screening in routine clinical practice. Gynecologic Oncology, 121, 309-311. doi:
8. Massad, L. S., Seaberg, E. C., Wright, R. L., Darragh, T., Lee, Y., Colie, C., Burk, R. (2008). Squamous cervical lesions in women with human immunodeficiency virus. Obstetrics & Gynecology, 111, 1388-1393.
9. Moore, G., Fetterman, B., Cox, J. T., Poitras, N., Lorey, T., Kinney, W., & Castle, P. E. (2010). Lessons from practice: Risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24. Journal of Lower Genital Tract Disease, 14, 97-102. doi:
10. Moscicki, A. B. (2007). HPV infections in adolescents. Disease Markers, 23, 229-234.
11. Moscicki, A. B. (2010). Human papillomavirus disease and vaccines in adolescents. Adolescent Medicine: State of the Art Reviews, 21, 347-362.
12. Moscicki, A. B., & Cox, J. T. (2010). Practice improvement in cervical screening and management (PICSM): Symposium on management of cervical abnormalities in adolescents and young women. Journal of Lower Genital Tract Disease, 14, 73-80.
13. Moscicki, A. B., Ma, Y., Wibbelsman, C., Powers, A, Darragh, T. M., Nozzari, S., Shiboski, S. (2008). Risks for cervical intraepithelial neoplasia-3 among adolescent and young women with abnormal cytology. Obstetrics and Gynecology, 112, 1335-1342. doi:
14. Rodriguez, R., & Fadare, O. (2007). Longitudinal cytological follow-up of patients with a papanicolaou test interpretation of atypical squamous cells of undetermined significance that was followed by a negative reflex test for high-risk human papillomavirus types. International Journal of Gynecological Pathology, 27, 108-112. doi:
15. Smith, R. A., Cokkinides, V., Brooks, D., Saslow, D., Shah, M. & Brawley, O. W. (2011). Cancer screening in the US, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA: A Cancer Journal for Clinicians 2011, 61, 8-30. doi:
16. Soren, K., Kharbanda, E. O., Chen, S., & Westhoff, C. (2009). A 6-year experience with pap smears in an urban adolescent practice: The scope and burden of abnormalities. Journal of Pediatric and Adolescent Gynecology, 22, 217-222. doi:
17. Spitzer, M. (2007). Screening and management of women and girls with human papillomavirus infection. Gynecologic Oncology, 107, S14-S18. doi:
18. Stanley, M. (2010). Pathology and epidemiology of HPV infection in females. Gynecologic Oncology, 117, S5-S10. doi:
19. Sycuro, L. K., Xi, L. F., Hughes, J. P., Feng, Q., Winer, R. L., Lee, S. K., Koutsky, L. A. (2008). Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. Journal of Infectious Diseases, 198, 971-978. doi:
20. U.S. Cancer Statistics Working Group. (2010). United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta, GA : Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; Retrieved from
21. Veldhuijzen, N. J., Snijders, P. J., Reiss, P., Meijer, C. J., & van de Wijgert, J. H. (2010). Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Disease, 10, 862-874. doi:
22. Widdice, L. E., & Moscicki, A. B. (2008). Updated guidelines for papanicolaou tests, colposcopy, and human papillovirus testing in adolescents. Journal of Adolescent Health, 43, S41-S51. doi:
23. Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007). 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. American Journal of Obstetrics and Gynecology, 197, 346-355. doi:
24. Yoost, J. L., Goetzl, L., Hoda, R., Soper, D. E., & Barry, A. (2009). Management of the low grade squamous intraepithelial lesion pap smear in a cross-sectional, observational cohort. Journal of Reproductive Medicine, 54, 421-424.